Thymosin Alpha-1
A naturally occurring thymic peptide used clinically as an immunomodulator for chronic viral infections and immune support.
Overview
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide produced by the thymus. It's approved in many countries for hepatitis B and C and is widely used as an immune modulator — especially for chronic infection, post-illness recovery, and complex inflammatory cases.
Benefits
- Modulates immune response toward balance
- Supports T-cell maturation and function
- Used clinically for chronic viral infection
- May aid post-illness recovery
Mechanism of Action
Activates Toll-like receptors on dendritic cells and supports T-cell differentiation and maturation, restoring balanced immune signaling without broad immunosuppression.
Dosage (informational only)
- Typical range
- 1.6 mg per dose
- Frequency
- Twice weekly subcutaneously
Approved protocols vary by indication. Long courses may be required for chronic conditions.
Side Effects
- Generally well-tolerated
- Possible injection site reactions
- Mild flu-like symptoms early in therapy
Related peptides
A pentadecapeptide derived from a gastric protein, widely studied for its regenerative and cytoprotective effects.
A synthetic fragment of Thymosin Beta-4 widely used in injury recovery research and frequently stacked with BPC-157.
A short tripeptide fragment of α-MSH studied for anti-inflammatory effects in the gut and skin without pigmentation effects.